Teva, Boehringer Slapped With New Pay-For-Delay Suit
Teva Pharmaceuticals Inc. and Boehringer Ingelheim Pharmaceuticals Inc. were slapped on Friday with another proposed class action, this one in Pennsylvania federal court, over an alleged $120 million deal to delay...To view the full article, register now.
Already a subscriber? Click here to view full article